Related Articles
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma
PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I
High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer